CORDIS
EU research results

CORDIS

English EN

Novel Personalized Cellular Therapy Approach for Immune Diseases

Project information

Grant agreement ID: 812021

Status

Ongoing project

  • Start date

    1 July 2018

  • End date

    30 June 2021

Funded under:

H2020-EU.3.

H2020-EU.2.3.

H2020-EU.2.1.

  • Overall budget:

    € 3 850 000

  • EU contribution

    € 2 695 000

Coordinated by:

TLA TARGETED IMMUNOTHERAPIES AB

Sweden

Periodic Reporting for period 1 - TLA-Gut (Novel Personalized Cellular Therapy Approach for Immune Diseases)

Reporting period: 2018-07-01 to 2019-06-30

Project information

Grant agreement ID: 812021

Status

Ongoing project

  • Start date

    1 July 2018

  • End date

    30 June 2021

Funded under:

H2020-EU.3.

H2020-EU.2.3.

H2020-EU.2.1.

  • Overall budget:

    € 3 850 000

  • EU contribution

    € 2 695 000

Coordinated by:

TLA TARGETED IMMUNOTHERAPIES AB